Drugmakers Including Pfizer, Sanofi And Takeda Plan To Raise Prices In The US On More Than 500 Unique Drugs In Early January
Portfolio Pulse from Charles Gross
Pfizer, Sanofi, and Takeda are set to increase prices on over 500 unique drugs in the US in early January, according to data from 3 Axis Advisors reported by Reuters.
December 29, 2023 | 2:17 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pfizer is among the drugmakers raising prices on several drugs in the US, which could lead to increased revenues but also potential public and political scrutiny.
While the price increase may lead to higher short-term revenues for Pfizer, it could also result in negative public perception and political pressure that may affect the stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Sanofi is set to increase prices on some drugs in the US, which may contribute to higher short-term sales but could also attract negative attention from consumers and lawmakers.
Sanofi's price hikes could boost its short-term revenue, but the company must balance this with the risk of increased scrutiny and potential regulatory action.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Takeda will raise prices on certain drugs in the US, potentially increasing its revenue but also facing the risk of public backlash and regulatory attention.
Takeda's decision to raise drug prices may lead to higher revenues, but it also carries the risk of negative public and political reactions that could impact the stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80